{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:27:53Z","timestamp":1794313673784,"version":"4.9.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["16\/SPP\/3303"],"award-info":[{"award-number":["16\/SPP\/3303"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["GOIPG\/2025\/7269l"],"award-info":[{"award-number":["GOIPG\/2025\/7269l"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtha.2026.04.035","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:08:00Z","timestamp":1778760480000},"page":"2842-2848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CX3CR1+ synovial macrophages accumulate in the joint during experimental hemophilic arthropathy but are not required for acute synovitis"],"prefix":"10.1016","volume":"24","author":[{"given":"Alexander G.","family":"Lawrence","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatenda","family":"Murangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ivers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Turecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8401-7293","authenticated-orcid":false,"given":"Padraic G.","family":"Fallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.04.035_bib1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.7326\/M19-1208","article-title":"Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries","volume":"171","author":"Iorio","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2026.04.035_bib2","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/j.1538-7836.2010.03962.x","article-title":"Blood-induced joint disease: the pathophysiology of hemophilic arthropathy","volume":"8","author":"Valentino","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.035_bib3","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/bloodadvances.2019001311","article-title":"Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study","volume":"4","author":"Warren","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.04.035_bib4","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ymthe.2019.11.006","article-title":"A molecular revolution in the treatment of hemophilia","volume":"28","author":"Butterfield","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.jtha.2026.04.035_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/JBM.S304597","article-title":"Asymptomatic joint bleeding and joint health in hemophilia: a review of variables, methods, and biomarkers","volume":"12","author":"Gooding","year":"2021","journal-title":"J Blood Med"},{"key":"10.1016\/j.jtha.2026.04.035_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2516.2011.02682.x","article-title":"Identification and long-term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis","volume":"18","author":"Olivieri","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.035_bib7","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/hae.15097","article-title":"Pathogenesis of osteoarthritis, rheumatoid arthritis, and hemophilic arthropathy: the role of angiogenesis","volume":"30","author":"Caliogna","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.035_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.905356","article-title":"Synovial macrophages: past life, current situation, and application in inflammatory arthritis","volume":"13","author":"Bai","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2026.04.035_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00774-024-01520-8","article-title":"Inflammatory diseases causing joint and bone destruction: rheumatoid arthritis and hemophilic arthropathy","volume":"42","author":"Terashima","year":"2024","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jtha.2026.04.035_bib10","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/jth.12176","article-title":"IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia","volume":"11","author":"Narkbunnam","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.035_bib11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/a-2071-0477","article-title":"Activation of the acute-phase response in hemophilia","volume":"123","author":"Knowles","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.035_bib12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41584-019-0323-6","article-title":"Chemokines in rheumatic diseases: pathogenic role and therapeutic implications","volume":"15","author":"Miyabe","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jtha.2026.04.035_bib13","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.4110\/in.2018.18.e5","article-title":"Tissue-specific role of CX(3)CR1 expressing immune cells and their relationships with human disease","volume":"18","author":"Lee","year":"2018","journal-title":"Immune Netw"},{"key":"10.1016\/j.jtha.2026.04.035_bib14","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41586-019-1471-1","article-title":"Locally renewing resident synovial macrophages provide a protective barrier for the joint","volume":"572","author":"Culemann","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2026.04.035_bib15","article-title":"Comparative analysis of the occurrence and role of CX3CL1 (fractalkine) and its receptor CX3CR1 in hemophilic arthropathy and osteoarthritis","volume":"2020","author":"Wojdasiewicz","year":"2020","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jtha.2026.04.035_bib16","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1182\/blood.2024027578","article-title":"The interleukin-33 receptor (ST2) is a novel therapeutic target to attenuate the progression of hemophilic arthropathy","volume":"146","author":"Hawerkamp","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.04.035_bib17","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1128\/MCB.20.11.4106-4114.2000","article-title":"Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion","volume":"20","author":"Jung","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jtha.2026.04.035_bib18","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2516.2008.01973.x","article-title":"IL-1 beta, IL-6, KC and MCP-1 are elevated in synovial fluid from haemophilic mice with experimentally induced haemarthrosis","volume":"15","author":"Ovlisen","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.035_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/978-1-4939-8997-3_25","article-title":"Immunostaining of skeletal tissues","volume":"1914","author":"Roelofs","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jtha.2026.04.035_bib20","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1182\/blood.2019003824","article-title":"EPCR deficiency or function-blocking antibody protects against joint bleeding\u2013induced pathology in hemophilia mice","volume":"135","author":"Magisetty","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.04.035_bib21","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/hae.13672","article-title":"Bleed volume of experimental knee haemarthrosis correlates with the subsequent degree of haemophilic arthropathy","volume":"25","author":"Vols","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.035_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112984","article-title":"Synergy of 5-aminolevulinate supplement and CX3CR1 suppression promotes liver regeneration via elevated IGF-1 signaling","volume":"42","author":"Chen","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.jtha.2026.04.035_bib23","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/art.34320","article-title":"Decreased Th17 and antigen-specific humoral responses in CX(3) CR1-deficient mice in the collagen-induced arthritis model","volume":"64","author":"Tarrant","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtha.2026.04.035_bib24","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/art.27470","article-title":"Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model","volume":"62","author":"Jacobs","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtha.2026.04.035_bib25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/BJ20150520","article-title":"AZD8797 is an allosteric non-competitive modulator of the human CX3CR1 receptor","volume":"473","author":"Cederblad","year":"2016","journal-title":"Biochem J"},{"key":"10.1016\/j.jtha.2026.04.035_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj1252","article-title":"Loss of synovial tissue macrophage homeostasis precedes rheumatoid arthritis clinical onset","volume":"10","author":"Hanlon","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.jtha.2026.04.035_bib27","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood-2015-09-665091","article-title":"Inflammation is key to hemophilic arthropathy","volume":"126","author":"Srivastava","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.04.035_bib28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.phrs.2016.11.032","article-title":"Pathophysiology of hemophilic arthropathy and potential targets for therapy","volume":"115","author":"Pulles","year":"2017","journal-title":"Pharmacol Res"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626002874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626002874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:15:57Z","timestamp":1794312957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626002874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1538783626002874"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.04.035","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CX3CR1+ synovial macrophages accumulate in the joint during experimental hemophilic arthropathy but are not required for acute synovitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}